Detection of drug resistance pattern among Gram-negative isolates

Paper Details

Research Paper 20/03/2024
Views (241) Download (31)
current_issue_feature_image
publication_file

Detection of drug resistance pattern among Gram-negative isolates

S. Jayashree, Mita D. Wadekar, C. Pooja, J. V. Sathish
Int. J. Micro. Myco.18( 3), 1-6, March 2024.
Certificate: IJMM 2024 [Generate Certificate]

Abstract

Both Gram-positive and Gram-negative bacteria are one of the main causes of infections in humans. Now a day, antimicrobial resistance (AMR) is considered as main public health threat, also AMR bacteria in different hospital wards are increasing significantly. Increasing number of extended spectrum beta-lactamase (ESBL) producers has reduced the treatment options which resulted in emergence of multidrug resistant strains, treatment failure and hence increased mortality. To know the drug resistance pattern among gram negative isolates and detection of ESBL production. A retrospective study of all gram negative isolates was conducted. Total of 177 isolates were isolated from various clinical samples. They were processed and identified by standard Microbiological procedures. The antibiotics susceptibility testing was performed by Kirby- Bauer disc diffusion method using CLSI guidelines. ESBL was detected by combined disc test using ceftazidime (30μg) alone and in combination with clavulanic acid disc. Of 285 samples processed, 177 Gram-negative isolates were isolated which includes E. coli, Klebsiella spp., Pseudomonas aeruginosa, Proteus spp., Citrobacter spp., Enterobacter spp., and Acinetobacter spp. Males 104 (58.8%) were commonly involved as compared to females 73 (41.2%).Of 177 isolates tested,90(50.8%) are from urine sample, 83(46.9%) from pus sample and 4(2.3%) from blood sample. ESBL was detected in 92 (52%) isolates. They showed least resistance to amikacin 36 (20.3%), piperacillin-tazobactam 30 (16.9%) and meropenem 10 (5.6%). Our study showed most of the isolates was resistant to commonly used penicillin and cephalosporin group of antibiotics and also showed 52% prevalence of ESBL producers. Judicious use of antibiotics, detection and reporting of beta-lactamase enzymes helps in combating spread of MDR bacteria and also helps in appropriate treatment.

VIEWS 42

Affolabi D, Sogbo F, Bankole H, Hounkpe W, Senou S, Barogui Y, Anagonou S, Boko M, Akpona F. 2017. Rapid detection of extended-spectrum-beta-lactamase producing Enterobacteriaceae in blood cultures using the ESBL NDP test in Cotonou, Benin. Journal of Medical Microbiology 66, 884–887. https://doi.org/10.1099/jmm.0.000520.

Afifi SS, Helal Z, Hassan SS, Kamal ST. 2015. Analysis of GNB species and pattern of resistance responsible for LRTI in patients with cancer. American Journal of Biomedical and Life Sciences 3(2), 25-32.

Azimi T, Maham S, Fallah F, Azimi L, Gholinejad Z. 2019. Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children’s Hospital, Tehran, Iran: 2013–2018. Infection and Drug Resistance 12, 2089–2102.

Batchoun RG, Swedan SF, Shurman AM. 2009. Extended-spectrum β-lactamases among Gram-negative bacterial isolates from clinical specimens in three major hospitals in Northern Jordan. International Journal of Microbiology, 1-8.

Clinical Laboratory Standards Institutes (CLSI). 2019. Performance standards for antimicrobial susceptibility testing. 29th ed. CLSI Supplement M100. Wayne, Pennsylvania, USA: National Committee for Clinical Laboratory Standards.

Collee JG, Marmion BP, Fraser AG, Simmons A. 1996. Mackie and McCartney Practical Medical Microbiology, 14th ed. Edinburgh: Churchill Livingstone.

Elbadawi HS, Elhag KM, Mahgoub E, Altayb HN, Abdel Hamid MM. 2019. Antimicrobial resistance surveillance among Gram-negative bacterial isolates from patients in hospitals in Khartoum State, Sudan [version 1; peer review: awaiting peer review]. F1000Research 8(156), 1-11.

Ghimire A, Acharya B, Tuladhar R. 2017. Extended spectrum β-lactamase (ESBL) producing multidrug-resistant Gram-negative bacteria from various clinical specimens of patients visiting a tertiary care hospital. TUJM 4(1), 1-8.

Jose LR. 2017. Detection of ESBL organisms in body fluids, a study from a tertiary care center. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) 16(8), 48-51.

Khan MN, Srivastava P, Chophi V, Nirwan PS. 2015. Prevalence of ESBL and AmpC β-lactamase in Gram-negative bacilli in various clinical samples at tertiary care hospital. International Research Journal of Medical Sciences 3(8), 1-6.

Lamichhane B, Thakur C, Jain SK. 2014. Antibiotic resistance patterns of Gram-negative isolates in a tertiary care hospital of Nepal. Asian Journal of Pharmaceutical and Clinical Research 7(3), 30-33.

Moses A, Bwanga F, Boum Y, Bazira J. 2014. Prevalence and genotypic characterization of extended-spectrum beta-lactamases produced by Gram-negative bacilli at a tertiary care hospital in rural South Western Uganda. Author manuscript 4(12), 1541–1550.

Ogefere HO, Ighoroge AD, Ighoroge EO, Egbe CA, Enabulele IO. 2015. Extended-spectrum beta-lactamase (ESBL)–producing Gram-negative isolates from urine and wound specimens in a tertiary health facility in Southern Nigeria. Tropical Journal of Pharmaceutical Research 14(6), 1089-1094. https://doi.org/10.4314/tjpr.v14i6.26.

Phamba SG, Dominic R M. 2017. Prevalence of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli among clinical isolates in a tertiary care hospital. Journal of International Medicine and Dentistry 4(1), 06-12.

Reta A, Kifilie AB, Mengist A. 2019. Bacterial infections and their antibiotic resistance pattern in Ethiopia: a systematic review. Hindawi Advances in Preventive Medicine, 1-10.

Sandhu R, Aggarwal A, Sayal P, Kumar S. 2019. Intestinal carriage of drug-resistant Gram-negative bacteria belonging to family Enterobacteriaceae in children aged 3–14 years: an emerging threat. International Journal of Health & Allied Sciences 8(2), 108-115.

Saxena A, Singh S, Goyal R, Saxena S. 2019. Antibiotic susceptibility pattern of extended spectrum β-lactamase ESBL producing Gram-negative bacilli in a tertiary care teaching hospital, Bareilly, India. International Journal of Basic and Clinical Pharmacology 8, 228-233.

Shehkar HH, Shadmehr P, Mahmoodpoor A, Mashayekhi SO, Entezari-Maleki T. 2016. Antimicrobial susceptibility patterns among bacteria isolated from intensive care units of the largest teaching hospital at the northwest of Iran. Brazilian Journal of Pharmaceutical Sciences 52(3), 43-412.

Shilpakar A, Ansari M, Rai KR, Rai G, Rai SK. 2021. Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gram-negative isolates from clinical samples in a tertiary care hospital of Nepal. Tropical Medicine and Health 49, 23. https://doi.org/10.1186/s41182-021-00311-3.

Uc-Cachón AH, Gracida-Osorno C, Luna-Chi IG, Jiménez-Guillermo JG, Molina-Salinas GM. 2019. High prevalence of antimicrobial resistance among Gram-negative isolated bacilli in intensive care units at a tertiary-care hospital in Yucatán Mexico. Medicina 55(588), 1-13.

Ullah A, Durrani R, Ullah I, Rafiq M. 2012. Antibiotic resistance profile of clinical Gram-negative bacteria. Journal of Biological and Food Science Research 1(2), 23-25.

Veena Kumari HB, Nagarathna S, Chandramuki A. 2007. Antimicrobial resistance pattern among aerobic Gram-negative bacilli of lower respiratory tract specimens of intensive care unit patients in a neurocentre. The Indian Journal of Chest Diseases & Allied Sciences 49, 19-22.

Walker GT, Quan J, Higgins SG, Toraskar N, Chang W, Saeed A, Sapiro V, Pitzer K, Whitfield N, Lopansri BK, Motyl M, Sahm D. 2019. Predicting Antibiotic Resistance in Gram-Negative Bacilli from Resistance Genes. Antimicrob Agents Chemother 63(4), e02462-18. DOI: 10.1128/AAC.02462-18.

Zaman RM, Aly MM, Helmi NR. 2015. Antimicrobial susceptibility pattern of gram-negative bacilli isolated from a teaching hospital in Jeddah, Saudi Arabia. African Journal of Microbiology Research 9(41), 2145-2158.